376 related articles for article (PubMed ID: 34482403)
1. Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.
Yang F; Long N; Anekpuritanang T; Bottomly D; Savage JC; Lee T; Solis-Ruiz J; Borate U; Wilmot B; Tognon C; Bock AM; Pollyea DA; Radhakrishnan S; Radhakrishnan S; Patel P; Collins RH; Tantravahi S; Deininger MW; Fan G; Druker B; Shinde U; Tyner JW; Press RD; McWeeney S; Agarwal A
Blood; 2022 Feb; 139(8):1208-1221. PubMed ID: 34482403
[TBL] [Abstract][Full Text] [Related]
2. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
3. The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencing.
Maierhofer A; Mehta N; Chisholm RA; Hutter S; Baer C; Nadarajah N; Pohlkamp C; Thompson ER; James PA; Kern W; Haferlach C; Meggendorfer M; Haferlach T; Blombery P
Blood Adv; 2023 Dec; 7(23):7346-7357. PubMed ID: 37874914
[TBL] [Abstract][Full Text] [Related]
4. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
Stubbins RJ; Korotev S; Godley LA
Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
[TBL] [Abstract][Full Text] [Related]
5. Frequency of pathogenic/likely pathogenic germline variants in cancer-related genes among children with acute leukemia in Saudi Arabia.
Alsultan A; Essa M; Aljefri A; Ayas M; Alharbi M; Alkhayat N; Al-Anzi F; Yassin F; Alkasim F; Alharbi Q; Abdullah S; Jastaniah W
Pediatr Blood Cancer; 2020 Jul; 67(7):e28340. PubMed ID: 32359129
[TBL] [Abstract][Full Text] [Related]
6. ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants.
Luo X; Feurstein S; Mohan S; Porter CC; Jackson SA; Keel S; Chicka M; Brown AL; Kesserwan C; Agarwal A; Luo M; Li Z; Ross JE; Baliakas P; Pineda-Alvarez D; DiNardo CD; Bertuch AA; Mehta N; Vulliamy T; Wang Y; Nichols KE; Malcovati L; Walsh MF; Rawlings LH; McWeeney SK; Soulier J; Raimbault A; Routbort MJ; Zhang L; Ryan G; Speck NA; Plon SE; Wu D; Godley LA
Blood Adv; 2019 Oct; 3(20):2962-2979. PubMed ID: 31648317
[TBL] [Abstract][Full Text] [Related]
7. Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia.
Churpek JE; Pyrtel K; Kanchi KL; Shao J; Koboldt D; Miller CA; Shen D; Fulton R; O'Laughlin M; Fronick C; Pusic I; Uy GL; Braunstein EM; Levis M; Ross J; Elliott K; Heath S; Jiang A; Westervelt P; DiPersio JF; Link DC; Walter MJ; Welch J; Wilson R; Ley TJ; Godley LA; Graubert TA
Blood; 2015 Nov; 126(22):2484-90. PubMed ID: 26492932
[TBL] [Abstract][Full Text] [Related]
8. The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants.
Rio-Machin A; Vulliamy T; Hug N; Walne A; Tawana K; Cardoso S; Ellison A; Pontikos N; Wang J; Tummala H; Al Seraihi AFH; Alnajar J; Bewicke-Copley F; Armes H; Barnett M; Bloor A; Bödör C; Bowen D; Fenaux P; Green A; Hallahan A; Hjorth-Hansen H; Hossain U; Killick S; Lawson S; Layton M; Male AM; Marsh J; Mehta P; Mous R; Nomdedéu JF; Owen C; Pavlu J; Payne EM; Protheroe RE; Preudhomme C; Pujol-Moix N; Renneville A; Russell N; Saggar A; Sciuccati G; Taussig D; Toze CL; Uyttebroeck A; Vandenberghe P; Schlegelberger B; Ripperger T; Steinemann D; Wu J; Mason J; Page P; Akiki S; Reay K; Cavenagh JD; Plagnol V; Caceres JF; Fitzgibbon J; Dokal I
Nat Commun; 2020 Feb; 11(1):1044. PubMed ID: 32098966
[TBL] [Abstract][Full Text] [Related]
9. The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms.
Li P; Brown S; Williams M; White T; Xie W; Cui W; Peker D; Lei L; Kunder CA; Wang HY; Murray SS; Vagher J; Kovacsovics T; Patel JL
Blood; 2022 Aug; 140(7):716-755. PubMed ID: 35671390
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma.
Kim J; Light N; Subasri V; Young EL; Wegman-Ostrosky T; Barkauskas DA; Hall D; Lupo PJ; Patidar R; Maese LD; Jones K; Wang M; Tavtigian SV; Wu D; Shlien A; Telfer F; Goldenberg A; Skapek SX; Wei JS; Wen X; Catchpoole D; Hawkins DS; Schiffman JD; Khan J; Malkin D; Stewart DR
JCO Precis Oncol; 2021; 5():. PubMed ID: 34095712
[TBL] [Abstract][Full Text] [Related]
11. Germline DDX41 mutations define a significant entity within adult MDS/AML patients.
Sébert M; Passet M; Raimbault A; Rahmé R; Raffoux E; Sicre de Fontbrune F; Cerrano M; Quentin S; Vasquez N; Da Costa M; Boissel N; Dombret H; Peffault de Latour R; Socié G; Itzykson R; Fenaux P; Soulier J; Adès L; Clappier E
Blood; 2019 Oct; 134(17):1441-1444. PubMed ID: 31484648
[TBL] [Abstract][Full Text] [Related]
12. AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome.
Li P; White T; Xie W; Cui W; Peker D; Zeng G; Wang HY; Vagher J; Brown S; Williams M; Kovacsovics T; Patel JL
Leukemia; 2022 Mar; 36(3):664-674. PubMed ID: 34671111
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinical implications of germline predisposition gene mutations in patients with acute myeloid leukemia.
Kim B; Yun W; Lee ST; Choi JR; Yoo KH; Koo HH; Jung CW; Kim SH
Sci Rep; 2020 Aug; 10(1):14297. PubMed ID: 32868804
[TBL] [Abstract][Full Text] [Related]
14. KMT2A-D pathogenicity, prevalence, and variation according to a population database.
Larson JK; Hunter-Schlichting DN; Crowgey EL; Mills LJ; Druley TE; Marcotte EL
Cancer Med; 2023 Mar; 12(6):7234-7245. PubMed ID: 36479909
[TBL] [Abstract][Full Text] [Related]
15. Novel Candidate
Andrés-Zayas C; Suárez-González J; Chicano-Lavilla M; Bastos Oreiro M; Rodríguez-Macías G; Font López P; Osorio Prendes S; Oarbeascoa Royuela G; García Ramírez P; Nieves Salgado R; Gómez-Centurión I; Carbonell Muñoz D; Muñiz P; Kwon M; Díez-Martín JL; Buño I; Martínez-Laperche C
Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765901
[TBL] [Abstract][Full Text] [Related]
16. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
[TBL] [Abstract][Full Text] [Related]
17. Identifying patients with genetic predisposition to acute myeloid leukemia.
Obrochta E; Godley LA
Best Pract Res Clin Haematol; 2018 Dec; 31(4):373-378. PubMed ID: 30466750
[TBL] [Abstract][Full Text] [Related]
18. Identification of somatic mutations using whole-exome sequencing in Korean patients with acute myeloid leukemia.
Heo SG; Koh Y; Kim JK; Jung J; Kim HL; Yoon SS; Park JW
BMC Med Genet; 2017 Mar; 18(1):23. PubMed ID: 28249600
[TBL] [Abstract][Full Text] [Related]
19. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
Abdel-Rahman MH; Sample KM; Pilarski R; Walsh T; Grosel T; Kinnamon D; Boru G; Massengill JB; Schoenfield L; Kelly B; Gordon D; Johansson P; DeBenedictis MJ; Singh A; Casadei S; Davidorf FH; White P; Stacey AW; Scarth J; Fewings E; Tischkowitz M; King MC; Hayward NK; Cebulla CM
Ophthalmology; 2020 May; 127(5):668-678. PubMed ID: 32081490
[TBL] [Abstract][Full Text] [Related]
20. Specifications of the ACMG/AMP Variant Classification Guidelines for Germline
Hatton JN; Frone MN; Cox HC; Crowley SB; Hiraki S; Yokoyama NN; Abul-Husn NS; Amatruda JF; Anderson MJ; Bofill-De Ros X; Carr AG; Chao EC; Chen KS; Gu S; Higgs C; Machado J; Ritter D; Schultz KA; Soper ER; Wu MK; Mester JL; Kim J; Foulkes WD; Witkowski L; Stewart DR
Hum Mutat; 2023; 2023():. PubMed ID: 38084291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
